Trial Profile
Granulocyte-Colony Stimulating Factor Treatment for Crohn's Disease: A Pilot Study Assessing Immune and Clinical Response
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Filgrastim (Primary)
- Indications Crohn's disease
- Focus Pharmacodynamics; Therapeutic Use
- 31 Jan 2017 New trial record